Nasdaq Beam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq beam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Beam Today - Breaking & Trending Today

Beam Therapeutics (NASDAQ:BEAM) Trading 4.7% Higher

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares rose 4.7% during trading on Monday . The stock traded as high as $22.45 and last traded at $22.38. Approximately 76,700 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 1,433,598 shares. The stock had previously closed at $21.38. […] ....

United States , Johnm Evans , First Horizon Advisors Inc , Beam Therapeutics Inc , Fmr Llc , Riverview Trust Co , Fund Management Co , Securities Exchange Commission , Jpmorgan Chase Co , Royal Bank , Beam Therapeutics Company Profile , Board Of Administration Florida Retirement System , Beam Therapeutics , Get Free Report , Exchange Commission , Florida Retirement System , Horizon Advisors , Fund Management , Therapeutics Inc , Beam Therapeutics Daily , Nasdaq Beam ,

Beam Therapeutics (NASDAQ:BEAM) Shares Down 6.6%

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares were down 6.6% during mid-day trading on Thursday . The stock traded as low as $20.84 and last traded at $21.23. Approximately 468,916 shares changed hands during trading, a decline of 67% from the average daily volume of 1,435,909 shares. The stock had previously closed at […] ....

United States , Johnm Evans , Jpmorgan Chase Co , Riverview Trust Co , Securities Exchange Commission , National Bank , Beam Therapeutics Inc , First Horizon Advisors Inc , Financial Services Group Inc , Beam Therapeutics , Get Free Report , Therapeutics Trading Down , Exchange Commission , Horizon Advisors , Services Group , Therapeutics Inc , Beam Therapeutics Daily , Nasdaq Beam ,

Beam Therapeutics Inc. (NASDAQ:BEAM) Short Interest Up 9.2% in March

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 14,320,000 shares, an increase of 9.2% from the February 29th total of 13,110,000 shares. Based on an average daily volume of 1,420,000 shares, […] ....

United States , Johnm Evans , Blackrock Inc , Nikko Asset Management Americas Inc , Jpmorgan Chase Co , Vanguard Group Inc , Beam Therapeutics Inc , Jefferies Financial Group , Sumitomo Mitsui Trust Holdings Inc , Fmr Llc , Beam Therapeutics , Get Free Report , Therapeutics Trading Down , Street Corp , Mitsui Trust Holdings , Nikko Asset Management Americas , Asset Management Americas , Financial Group , Therapeutics Inc , Beam Therapeutics Daily , Nasdaq Beam ,

Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of "Hold" by Analysts

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Hold” from the thirteen research firms that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […] ....

New Zealand General , New Zealand , United States , Johnm Evans , Christine Bellon , Goldman Sachs Group Inc , Wellington Management Group , Vanguard Group Inc , American International Group Inc , Securities Exchange Commission , Royal Bank , Jpmorgan Chase Co , Financial Services Group Inc , Beam Therapeutics Inc , Beam Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Services Group , Management Group , Sachs Group , American International Group , International Group , Get Free , Therapeutics Inc , Beam Therapeutics Daily ,

Beam Therapeutics (NASDAQ:BEAM) Rating Reiterated by BMO Capital Markets

Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at BMO Capital Markets in a research report issued on Wednesday, Benzinga reports. They presently have a $57.00 target price on the stock. BMO Capital Markets’ target price suggests a potential upside of 68.29% from the stock’s previous close. […] ....

United States , New Zealand General , New Zealand , Christine Bellon , Jpmorgan Chase Co , Jefferies Financial Group , Financial Services Group Inc , Royal Bank , Wellington Management Group , Fmr Llc , Beam Therapeutics Inc , American International Group Inc , Beam Therapeutics Company Profile , Vanguard Group Inc , Goldman Sachs Group Inc , Beam Therapeutics , Get Free Report , Financial Group , Services Group , Management Group , Sachs Group , American International Group , International Group , Therapeutics Inc , Beam Therapeutics Daily , Nasdaq Beam ,